194 related articles for article (PubMed ID: 9020771)
1. Antisense gene inhibition by C-5-substituted deoxyuridine-containing oligodeoxynucleotides.
Gutierrez AJ; Matteucci MD; Grant D; Matsumura S; Wagner RW; Froehler BC
Biochemistry; 1997 Jan; 36(4):743-8. PubMed ID: 9020771
[TBL] [Abstract][Full Text] [Related]
2. Structure-activity relationships in cell culture.
Wagner RW
Ciba Found Symp; 1997; 209():142-54; discussion 154-7. PubMed ID: 9383574
[TBL] [Abstract][Full Text] [Related]
3. Site and mechanism of antisense inhibition by C-5 propyne oligonucleotides.
Moulds C; Lewis JG; Froehler BC; Grant D; Huang T; Milligan JF; Matteucci MD; Wagner RW
Biochemistry; 1995 Apr; 34(15):5044-53. PubMed ID: 7536034
[TBL] [Abstract][Full Text] [Related]
4. Potent and selective inhibition of gene expression by an antisense heptanucleotide.
Wagner RW; Matteucci MD; Grant D; Huang T; Froehler BC
Nat Biotechnol; 1996 Jul; 14(7):840-4. PubMed ID: 9631007
[TBL] [Abstract][Full Text] [Related]
5. Enhanced RNase H activity with methylphosphonodiester/phosphodiester chimeric antisense oligodeoxynucleotides.
Giles RV; Tidd DM
Anticancer Drug Des; 1992 Feb; 7(1):37-48. PubMed ID: 1311929
[TBL] [Abstract][Full Text] [Related]
6. Conjugation of an antisense oligodeoxynucleotide to ribonuclease h results in sequence-specific cleavage and intracellular inhibition of HCV gene expression.
Fukuma T; Walton CM; Wu CH; Wu GY
Bioconjug Chem; 2003; 14(2):295-301. PubMed ID: 12643739
[TBL] [Abstract][Full Text] [Related]
7. A novel anionic dendrimer for improved cellular delivery of antisense oligonucleotides.
Hussain M; Shchepinov M; Sohail M; Benter IF; Hollins AJ; Southern EM; Akhtar S
J Control Release; 2004 Sep; 99(1):139-55. PubMed ID: 15342187
[TBL] [Abstract][Full Text] [Related]
8. Efficient RNase H-directed cleavage of RNA promoted by antisense DNA or 2'F-ANA constructs containing acyclic nucleotide inserts.
Mangos MM; Min KL; Viazovkina E; Galarneau A; Elzagheid MI; Parniak MA; Damha MJ
J Am Chem Soc; 2003 Jan; 125(3):654-61. PubMed ID: 12526664
[TBL] [Abstract][Full Text] [Related]
9. Selective inhibition of A-Raf and C-Raf mRNA expression by antisense oligodeoxynucleotides in rat vascular smooth muscle cells: role of A-Raf and C-Raf in serum-induced proliferation.
Cioffi CL; Garay M; Johnston JF; McGraw K; Boggs RT; Hreniuk D; Monia BP
Mol Pharmacol; 1997 Mar; 51(3):383-9. PubMed ID: 9058592
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the RNase H cleavage kinetics and blood serum stability of the north-conformationally constrained and 2'-alkoxy modified oligonucleotides.
Honcharenko D; Barman J; Varghese OP; Chattopadhyaya J
Biochemistry; 2007 May; 46(19):5635-46. PubMed ID: 17411072
[TBL] [Abstract][Full Text] [Related]
11. Effects of 5-(N-aminohexyl)carbamoyl-2'-deoxyuridine on endonuclease stability and the ability of oligodeoxynucleotide to activate RNase H.
Ueno Y; Kumagai I; Haginoya N; Matsuda A
Nucleic Acids Res; 1997 Oct; 25(19):3777-82. PubMed ID: 9380497
[TBL] [Abstract][Full Text] [Related]
12. 2'-O-methyl-modified phosphorothioate antisense oligonucleotides have reduced non-specific effects in vitro.
Yoo BH; Bochkareva E; Bochkarev A; Mou TC; Gray DM
Nucleic Acids Res; 2004; 32(6):2008-16. PubMed ID: 15064360
[TBL] [Abstract][Full Text] [Related]
13. Antisense oligodeoxynucleotides: synthesis, biophysical and biological evaluation of oligodeoxynucleotides containing modified pyrimidines.
Sanghvi YS; Hoke GD; Freier SM; Zounes MC; Gonzalez C; Cummins L; Sasmor H; Cook PD
Nucleic Acids Res; 1993 Jul; 21(14):3197-203. PubMed ID: 8393563
[TBL] [Abstract][Full Text] [Related]
14. Cellular penetration and antisense activity by a phenoxazine-substituted heptanucleotide.
Flanagan WM; Wagner RW; Grant D; Lin KY; Matteucci MD
Nat Biotechnol; 1999 Jan; 17(1):48-52. PubMed ID: 9920268
[TBL] [Abstract][Full Text] [Related]
15. [The effect of antisense H-ras on growth and metastasis of a high metastatic tumor model of human hepatoma in nude mice LCI-D20].
Liao Y; Tang Z; Sun F
Zhonghua Yi Xue Za Zhi; 1996 Sep; 76(9):650-3. PubMed ID: 9275544
[TBL] [Abstract][Full Text] [Related]
16. Gene inhibition using antisense oligodeoxynucleotides.
Wagner RW
Nature; 1994 Nov; 372(6504):333-5. PubMed ID: 7969490
[TBL] [Abstract][Full Text] [Related]
17. Fine tuning of electrostatics around the internucleotidic phosphate through incorporation of modified 2',4'-carbocyclic-LNAs and -ENAs leads to significant modulation of antisense properties.
Zhou C; Liu Y; Andaloussi M; Badgujar N; Plashkevych O; Chattopadhyaya J
J Org Chem; 2009 Jan; 74(1):118-34. PubMed ID: 19055352
[TBL] [Abstract][Full Text] [Related]
18. Selection of antisense oligodeoxynucleotides against glutathione S-transferase Mu.
't Hoen PA; Out R; Commandeur JN; Vermeulen NP; van Batenburg FH; Manoharan M; van Berkel TJ; Biessen EA; Bijsterbosch MK
RNA; 2002 Dec; 8(12):1572-83. PubMed ID: 12515389
[TBL] [Abstract][Full Text] [Related]
19. Structure of translation initiation region of c-myc mRNA and thermostability of the c-myc mRNA/antisense ODN complex.
Tanaka T; Kurihara Y; Sakamoto T; Furusawa M; Kobayashi A; Katahira M; Takeuchi K; Sugimoto N; Uesugi S
Nucleic Acids Symp Ser; 1995; (34):135-6. PubMed ID: 8841589
[TBL] [Abstract][Full Text] [Related]
20. Selective binding of trisamine-modified phosphorothioate antisense DNA to target mRNA improves antisense activity and reduces toxicity.
Matsukura M; Okamoto T; Miike T; Sawai H; Shinozuka K
Biochem Biophys Res Commun; 2002 May; 293(5):1341-7. PubMed ID: 12054660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]